Skip to main content
MedPathMedPath Home
Clinical Trials/TCTR20210506003
TCTR20210506003
Completed
Not Applicable

eutrophil to Lymphocyte Ratio as A Marker in Patients with Non-arteritic Anterior Ischemic Optic Neuropathy in HRH Princess Maha Chakri Sirindhorn Medical Center:retrospective crossectional study

HRH Princess Mahachakri Sirindhorn Medical Center, Facalty of Medicine, Srinakharinwirot University0 sites16 target enrollmentMay 6, 2021
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionseutrophil to lypmphocte ratio in Non-arteritic Anterior Ischemic Optic Neuropathyneutrophil to lymphocyte ratio, Non-arteritic Anterior Ischemic Optic Neuropathy

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
eutrophil to lypmphocte ratio in Non-arteritic Anterior Ischemic Optic Neuropathy
Sponsor
HRH Princess Mahachakri Sirindhorn Medical Center, Facalty of Medicine, Srinakharinwirot University
Enrollment
16
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

The neutrophil lymphocyte ratio could be one of the marker that increase in NAION patients. The advantages of the neutrophil lymphocyte ratio were the low cost and the high availability of the resource. Moreover it could be used as the predictive factor for the visual outcomes of the NAION patients.

Registry
who.int
Start Date
May 6, 2021
End Date
June 12, 2020
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
HRH Princess Mahachakri Sirindhorn Medical Center, Facalty of Medicine, Srinakharinwirot University

Eligibility Criteria

Inclusion Criteria

  • •1\. Acute painless visual loss
  • •2\. Presence of relative afferent pupillary defect
  • •3\. Visual field defect which is compatible with disease
  • •4\. Optic nerve head change that is consistent with disease
  • •5\. No other abnormal ophthalmic findings that can mimic other ophthalmic disease

Exclusion Criteria

  • •1\. Subjects with underlying disease effected a blood test result e.g. inflammatory diseases, leukemia, thrombocytosis, and Multiple myeloma
  • •2\. History of smoking and alcohol drinking
  • •3\. Retinal diseases e.g. diabetic retinopathy, retinal vein occlusion and hypertensive retinopathy
  • •4\. Glaucoma diseases
  • •5\. Other Neuro\-opthalmic diseases 6\.the patient who received any kind of treatment for NAIO

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
The predictive relevance of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and mean platelet volume for the diagnosis of complicated acute appendicitisComplicated appendicitisAppendicitisBiomarkersLeukocyte CountsEmergencies
TCTR20230405006/A369
Not yet recruiting
Not Applicable
N/LP Ratio as Predictor of Mortality in Septic AKI PatientsAcute Kidney Injury Due to Sepsis
NCT05559086Mahmoud Kamel Mohamed Abd elhaq200
Completed
Not Applicable
Does Type of Anesthesia Influence Inflammation Change After Breast Surgery?Breast Cancer Female
NCT04172220Centro di Riferimento Oncologico - Aviano68
Unknown
Not Applicable
Evaluation of Neutrophil/Lymphocyte Ratio ,Platelet/Lymphocyte Ratio and CRP as Markers of Severity of Pre-eclampsiaPre-Eclampsia
NCT03630276Ain Shams University111
Completed
Not Applicable
Complete Blood Count-derived Indexes in Inflammatory Modic ChangesModic Changes
NCT06440096Veysel Delen, MD48